MARK KESSEL

CIK 1222013 · last filed 2019-09-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

16

Lifetime Open-Market Net

-$28.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VivoSim Labs, INC. (ONVO) Delisted Director 15,000 $2.04 $30.6K $0 4 2019-09-09
DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted Director 3,031,431 $15.50 $46.99M -$28.36M 7 2012-10-17
Oncotelic Therapeutics, Inc. (OXGN) Delisted Director 27,232,118 $0 5 2011-01-04

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-05-14 DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted Grant (A) $0 EDGAR
2010-04-20 DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted Other (J) +690,631 $0 EDGAR
2010-01-05 Oncotelic Therapeutics, Inc. (OXGN) Delisted Grant (A) +35,000 $39.9K EDGAR
2010-01-04 DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted Grant (A) $0 EDGAR
2009-12-10 Oncotelic Therapeutics, Inc. (OXGN) Delisted Grant (A) +30,000 $34.2K EDGAR
2009-07-22 Oncotelic Therapeutics, Inc. (OXGN) Delisted Other (J) +10,000,000 $12.48M EDGAR
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.